Tetsuri Kondo
Overview
Explore the profile of Tetsuri Kondo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamada R, Hibino M, Nakachi S, Higa H, Watanabe S, Maeda K, et al.
Intern Med
. 2025 Feb;
PMID: 39971297
We present the case of a patient with lung cancer who developed brachial plexitis following treatment with immunochemotherapy, which included atezolizumab and palliative radiotherapy for a metastatic cervical spine tumor....
2.
Kamada R, Hibino M, Higa H, Watanabe S, Maeda K, Tobe S, et al.
Mod Rheumatol Case Rep
. 2025 Feb;
PMID: 39891392
Granulomatosis with polyangiitis (GPA) rarely involves the urological system. Herein, we report the case of a 71-year-old man with GPA who presented with frequent urination and a computed tomography detected...
3.
Hibino M, Kasai Y, Higa H, Watanabe S, Kamada R, Tobe S, et al.
IDCases
. 2024 Sep;
38:e02082.
PMID: 39329048
•COVID-19-related MIS-A developed in a Japanese patient.•Acute MIS-A symptoms improved with steroid and immunoglobulin therapy.•Unilateral ureteral calcified stenosis observed in the late phase of MIS-A.•Ureteral calcification suggests microvasculopathy and multiorgan...
4.
Horiuchi S, Hibino M, Tobe S, Maeda K, Kamada R, Watanabe S, et al.
Am J Respir Crit Care Med
. 2024 May;
210(7):934-935.
PMID: 38748562
No abstract available.
5.
Hatazoe S, Hira D, Kondo T, Ueshima S, Okano T, Hamada S, et al.
AAPS PharmSciTech
. 2024 May;
25(5):109.
PMID: 38730125
Although inhalation therapy represents a promising drug delivery route for the treatment of respiratory diseases, the real-time evaluation of lung drug deposition remains an area yet to be fully explored....
6.
Fukai R, Nishida T, Sugimoto H, Hibino M, Horiuchi S, Kondo T, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672609
Surgery is the most effective treatment for early-stage lung cancer; however, it poses a higher physical burden than other treatment options. Therefore, understanding the perioperative course of patients is important....
7.
Kondo T, Tanigaki T, Hibino M, Horiuchi S, Maeda K, Tobe S, et al.
J Aerosol Med Pulm Drug Deliv
. 2024 Apr;
37(3):132-139.
PMID: 38648279
: The combined use of a pressurized metered-dose inhaler and valved holding chamber (pMDI+VHC) is recommended to improve efficiency and safety; however, aerosol release is likely to vary with the...
8.
Ichikawa T, Tajiri S, Yokoba M, Horimizu Y, Yamaguchi S, Kawakami A, et al.
Respir Med
. 2023 Nov;
219:107438.
PMID: 37913968
Background: and objective: This study examined the validity of sniff nasal inspiratory (SNIP) and reverse-sniff nasal expiratory pressures (RSNEP) for estimating respiratory muscle strength and for predicting poor life expectancy...
9.
Kondo T, Tanigaki T, Hibino M, Tajiri S, Horiuchi S, Maeda K, et al.
J Aerosol Med Pulm Drug Deliv
. 2023 May;
36(4):181-188.
PMID: 37219899
A pressurized metered dose inhaler combined with a valved holding chamber (pMDI+VHC) is used to prevent upper airway complications and improve the efficiency of inhaled drug delivery; however, the aerodynamic...
10.
Kondo T, Tanigaki T, Hibino M, Tajiri S, Horiuchi S, Maeda K, et al.
Respir Care
. 2022 Sep;
68(3):338-345.
PMID: 36100278
Background: Ellipta is a respiratory device that is a successor of the Diskus. A major difference between the devices is that Ellipta, especially the 2-strip type, includes a pair of...